CD103 Expression on Blastic Plasmacytoid Dendritic Cell Neoplasms in Peripheral Blood and Bone Marrow Samples

<p>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive neoplasm which is typically CD4+, CD56+, and CD123+. There is limited information regarding CD103 expression on blastic plasmacytoid dendritic cell neoplasms. We identified six cases of BPDCN and all six had at least part...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ron Lee (Author), Sally Ullery (Author), Ron Thomason (Author)
Formato: Livro
Publicado em: Archives of Hematology Case Reports and Reviews - Peertechz Publications, 2020-05-01.
Assuntos:
Acesso em linha:Connect to this object online.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_ahcrr_000022
042 |a dc 
100 1 0 |a Ron Lee  |e author 
700 1 0 |a  Sally Ullery  |e author 
700 1 0 |a Ron Thomason  |e author 
245 0 0 |a CD103 Expression on Blastic Plasmacytoid Dendritic Cell Neoplasms in Peripheral Blood and Bone Marrow Samples 
260 |b Archives of Hematology Case Reports and Reviews - Peertechz Publications,   |c 2020-05-01. 
520 |a <p>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive neoplasm which is typically CD4+, CD56+, and CD123+. There is limited information regarding CD103 expression on blastic plasmacytoid dendritic cell neoplasms. We identified six cases of BPDCN and all six had at least partial CD103 expression (31-92% positive) with the majority having significant expression of CD103. </p> 
540 |a Copyright © Ron Lee et al. 
546 |a en 
655 7 |a Case Report  |2 local 
856 4 1 |u https://doi.org/10.17352/ahcrr.000022  |z Connect to this object online.